Skip to main content
Skip to main content

Personalized immunotherapy selection for breast cancer

Share:
Tech ID:
17-046
Principal Investigator:
Professor Qing-Xiang Amy Sang and Professor Jinfeng Zhang
Licensing Manager:
Patents:
  • Patent Pending
Description:

Professors Sang and Zhang  have identified biomarkers that define subgroups of breast cancer and clinically useful classifiers for distinguishing breast cancer subtypes.  The present invention provides methods for selecting a therapy for a patient suffering from breast cancer based on expression levels of biomarkers.  The present invention also provides methods for treating breast cancer.